| Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. | |
| | |
MedLine Citation:
|
PMID: 16014643 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AIMS: The clinical outcome of severe acute myocarditis patients with cardiogenic shock who require circulatory support devices is not well known. We studied the survival and clinical courses of patients with fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation (ECMO) and compared them with those of patients with acute non-fulminant myocarditis. METHODS AND RESULTS: Patients with acute myocarditis were divided into the following two groups. Fourteen patients who required ECMO for cardiogenic shock were defined as having fulminant myocarditis (F group), whereas 13 patients who had an acute onset of symptoms, but did not have compromised, were defined as having acute non-fulminant myocarditis (NF group). In the F group, 10 patients were weaned successfully from percutaneous ECMO. Therefore, the overall acute survival rate was 71%. Patients who were not weaned from ECMO showed smaller left ventricular end-diastolic and end-systolic dimensions, thicker left ventricular wall, and higher creatine phosphokinase MB isoform levels than those who were weaned from ECMO. When compared with patients in the NF group, the fractional shortening in the F group was more severely decreased in the acute phase [F: 10+/-4 vs. NF: 23+/-8% (mean+/-SD), P<0.001], but recovered in the chronic phase (F: 33+/-7 vs. NF: 34+/-6%). The prevalence of adverse clinical events in both groups was similar during the follow-up period of 50 months. CONCLUSION: In patients with fulminant myocarditis, percutaneous ECMO is a highly effective form of a haemodynamic support. Once a patient recovers from inflammatory myocardial damage, the subsequent clinical outcome is favourable, similar to that observed in patients with acute non-fulminant myocarditis. |
| | |
Authors:
|
Yasuhide Asaumi; Satoshi Yasuda; Isao Morii; Hiroyuki Kakuchi; Yoritaka Otsuka; Atsushi Kawamura; Yoshikado Sasako; Takeshi Nakatani; Hiroshi Nonogi; Shunichi Miyazaki |
Related Documents
:
|
19520653 - Papillary muscle dyssynchrony as a cause of functional mitral regurgitation in non-isch... 16760233 - Thromboembolic complications in patients with arrhythmogenic right ventricular dysplasi... 6615193 - Exploratory laparotomy for potential abdominal sepsis in patients with multiple-organ f... |
Publication Detail:
|
Type: Comparative Study; Journal Article Date: 2005-07-13 |
Journal Detail:
|
Title: European heart journal Volume: 26 ISSN: 0195-668X ISO Abbreviation: Eur. Heart J. Publication Date: 2005 Oct |
Date Detail:
|
Created Date: 2005-09-30 Completed Date: 2006-03-21 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8006263 Medline TA: Eur Heart J Country: England |
Other Details:
|
Languages: eng Pagination: 2185-92 Citation Subset: IM |
Affiliation:
|
Division of Cardiology and Cardiovascular Surgery, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-0873, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Adult Aged Assisted Circulation / methods Case-Control Studies Critical Illness Echocardiography / methods Extracorporeal Membrane Oxygenation / methods* Female Follow-Up Studies Hemodynamics Humans Male Middle Aged Myocarditis / complications*, physiopathology Shock, Cardiogenic / etiology, physiopathology, therapy* Treatment Outcome Ventricular Dysfunction, Left / complications |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: VEGF inhibition and cytotoxic effect of aplidin in leukemia cell lines and cells from acute myeloid ...
Next Document: Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.